![]() |
[¶óÆ÷¸£½Ã¾È] ÇѾç´ëÇб³±¸¸®º´¿ø Ç÷¾×Á¾¾ç³»°ú ÇãÁØ¿µ ±³¼ö°¡ ÃÖ±Ù ¿¸° ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2022)¿¡¼ Blood Research ¿ì¼ö³í¹®»óÀ» ¼ö»óÇß´Ù.
ÇãÁØ¿µ ±³¼ö´Â À̹ø¿¡ 'Outcomes of bortezomib combination chemotherapies in autologous stem cell transplantation-ineligible patients with AL amyloidosis'¶ó´Â Á¦¸ñÀÇ ³í¹®À¸·Î ¼ö»óÀÚ·Î ¼±Á¤µÆ´Ù.
Çã ±³¼ö´Â ÇѾç´ëÇб³ÀǴ븦 Á¹¾÷ÇÏ°í °æÈñ´ëÇб³ ´ëÇпø¿¡¼ ¼®»çÇÐÀ§, ¼º±Õ°ü´ë ´ëÇпø¿¡¼ ¹Ú»çÇÐÀ§¸¦ ÃëµæÇß´Ù. ´ëÇѳ»°úÇÐȸ, ´ëÇÑÇ÷¾×ÇÐȸ, ´ëÇÑÁ¾¾ç³»°úÇÐȸ, ´ëÇÑÇ׾Ͽä¹ý¿¬±¸È¸, ¹Ì±¹¾Ï¿¬±¸Çùȸ(AACR), ¹Ì±¹Ç÷¾×ÇÐȸ (ASH) µî¿¡¼ Ȱ¹ßÇÑ È°µ¿À» Çϰí ÀÖ´Ù.
±è»ó±â ±âÀÚ bus19@rapportian.com
<ÀúÀÛ±ÇÀÚ © ¶óÆ÷¸£½Ã¾È, ¹«´Ü ÀüÀç ¹× Àç¹èÆ÷ ±ÝÁö>